NASDAQ:AUPH | Free Cash Flow | Aurinia Pharmaceuticals Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$32.56M
2025-12-31$45.67M
2025-03-31$1.3M
2024-12-31$30.11M
2024-03-31-$18.6M
2023-12-31$14.31M
2023-03-31-$31.67M
2022-12-31$10.45M
2022-03-31-$46.75M
2021-12-31-$25.92M
2021-03-31-$53.54M
2020-12-31$3.2M
2020-03-31-$22.61M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$135.66M
2024-12-31$44.39M
2023-12-31-$33.46M
2022-12-31-$79.53M
2021-12-31-$157.69M
2020-12-31-$69.86M
2019-12-31-$63.59M
2018-12-31-$51.61M